US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ホーム
投資
株式
ドイツ
TG
Lakefront Biotherapeutics NV (GXE) 銘柄情報

Lakefront Biotherapeutics NV (GXE)

24.60

0.00

( 0.00% )

更新日時： 22:43:03

Lakefront Biotherapeutics NV (GXE) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

24.60

( - )

買値

24.80

売値

24.88

出来高

0.00

0.00 日の範囲 0.00

22.78 52 週間の範囲 32.64

時価総額

前日終値

24.60

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

79,225 €

発行済株式数

65,897,071

配当利回り

PER

3.32

1 株当たり利益 (EPS)

7.42

歳入

1.04B

純利益

488.78M

Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company’s pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG51... Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company’s pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc. The company was formerly known as Galapagos NV and changed its name to Lakefront Biotherapeutics NV in May 2026. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

lakefrontbio.com

本社

Mechelen, Belgium

設立

1999

Lakefront Biotherapeutics NV is listed in the Healthcare sector of the Tradegate (DE) with ticker GXE. The last closing price for Lakefront Biotherapeutic... was 24.60 €. Over the last year, Lakefront Biotherapeutic... shares have traded in a share price range of 22.78 € to 32.64 €.

Lakefront Biotherapeutic... currently has 65,897,071 shares in issue. The market capitalisation of Lakefront Biotherapeutic... is 1.62 € billion. Lakefront Biotherapeutic... has a price to earnings ratio (PE ratio) of 3.32.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.68	-2.68987341772	25.28	25.28	24.42	585	24.71994872	DE
4	0.54	2.24438902743	24.06	25.28	23.3	844	23.93002172	DE
12	-0.42	-1.67865707434	25.02	26.4	22.78	583	24.10147631	DE
26	-3.02	-10.9341057205	27.62	30.5	22.78	697	26.51218291	DE
52	1.1	4.68085106383	23.5	32.64	22.78	1227	27.56824736	DE
156	-10.15	-29.2086330935	34.75	38.9	20.2	3976	26.72134416	DE
260	-36.16	-59.512837393	60.76	66.4	20.2	2796	27.55623247	DE

GXE - Frequently Asked Questions (FAQ)

What is the current Lakefront Biotherapeutics NV share price?

The current share price of Lakefront Biotherapeutics NV is 24.60 €

How many Lakefront Biotherapeutics NV shares are in issue?

Lakefront Biotherapeutics NV has 65,897,071 shares in issue

What is the market cap of Lakefront Biotherapeutics NV?

The market capitalisation of Lakefront Biotherapeutics NV is EUR 1.62B

What is the 1 year trading range for Lakefront Biotherapeutics NV share price?

Lakefront Biotherapeutics NV has traded in the range of 22.78 € to 32.64 € during the past year

What is the PE ratio of Lakefront Biotherapeutics NV?

The price to earnings ratio of Lakefront Biotherapeutics NV is 3.32

What is the cash to sales ratio of Lakefront Biotherapeutics NV?

The cash to sales ratio of Lakefront Biotherapeutics NV is 1.55

What is the registered address of Lakefront Biotherapeutics NV?

The registered address for Lakefront Biotherapeutics NV is SchaliEnhoevedreef 20 T, Mechelen, Antwerp, 2800

What is the Lakefront Biotherapeutics NV website address?

The website address for Lakefront Biotherapeutics NV is lakefrontbio.com

Which industry sector does Lakefront Biotherapeutics NV operate in?

Lakefront Biotherapeutics NV operates in the Biotechnology & Life Sciences sector

Insidia

Insidia 22秒前

I wonder what happened to AIG, Fifty One Labs, Auburn University and the $10 Million in funding 😂
Conventionally never brought up again

Chuck McQuade

Chuck McQuade 42秒前

Even after a long 3-day weekend to 'think it over,' the 40,050-share buy wall is still parked flat at 40 cents...

sagedono

sagedono 42秒前

The old head fake.

santafe2

santafe2 42秒前

They'll have to rename Miami, Waterworld by 2100. Probably much sooner than that. Maybe they'll just re-label it as the worlds largest water park.

flyfishingcherokee

flyfishingcherokee 1分前

Increase in price will be highly dependent on leaving OTC and listing on an exchange that is suitable for institutional investing.

pos_stock_hoarder

pos_stock_hoarder 1分前

I have to admit it. I agree with him!

https://featureassets.gocomics.com/assets/aa7f33b04658013fc18c005056a9545d?optimizer=image&width=1200&quality=85

subslover

subslover 2分前

As previously disclosed, on June 9, 2026, the Centers for Medicare & Medicaid Services ("CMS") informed Clover Health Investments, Corp. (the "Company") that, consistent with a court judgment in Clover Insurance Co. V. HHS, Civ. A. No. 25-142 (S.D. Ga), CMS had recalculated the 2026 Star Rating for

DR_rugby

DR_rugby 2分前

GME buys more EBay

https://www.sec.gov/Archives/edgar/data/1065088/000119312526276853/d32649d425.htm

4.343m
39m options due 2/2028

Outstanding EBay 444m shares

9.8% ownership and growing

GLTA

BEIJING BILL

BEIJING BILL 2分前

Shorts and naysayers have an agenda ... this runaway train is about to lesave the station .. .

pos_stock_hoarder

pos_stock_hoarder 2分前

I have to admit it. I agree with him!

https://featureassets.gocomics.com/assets/aa7f33b04658013fc18c005056a9545d?optimizer=image&width=1200&quality=85

fza

The stock price keeps fluctuating and holding at .11 for quite some time. A good PR with an indication of a product line, quantities of silk is just around the corner. Come on Kim give us a PR that takes us out of the .11 limbo. It is coming!!!!

Denisk

Qtr 2 number is not accurate, right since qtr has not ended yet

pos_stock_hoarder

pos_stock_hoarder 4分前

Here comes another painful groaner!

https://featureassets.gocomics.com/assets/7f7651704ca7013fc18c005056a9545d?optimizer=image&width=1200&quality=85

Zadie420

Zadie420 4分前

I am not chartist. What does that mean? Tia

Slojab

"Is"? Everything the company has put out on La Palmichala over the years, including poor revenue numbers, dispute this. But let's gloss over the financials they've put out, right?

The NI 43-101 review confirms that La Palmichala is a robust, cash-flowing gold asset with substantial ex

BottomBounce

BottomBounce 5分前

Beyond Meat $BYND

Smartypants2

Smartypants2 5分前

Meitze, Thanks for that clarification! Where did your information come from?

BottomBounce

BottomBounce 5分前

Beyond Meat $BYND

Stinger2014

Stinger2014 5分前

Check the elevator———!
V

cashclan

cashclan 6分前

Depends on mechanics ...

Naysayer's are out in droves...

so, someone is out and about looking out for their pockets...

$300 I think is built into the pudding ...when? Lets say by the 3rd quarter?

EpicSage

EpicSage 6分前

$VSEE VSee Health Highlights Business Operations and Financial Success After Recent Strategic Sale
https://static.wixstatic.com/media/9fe7c2_c72fe122d2f648c593f12539b4bcb472~mv2.png/v1/fill/w_740,h_416,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/9fe7c2_c72fe122d2f648c593f12539b4bcb472~

PennyMillions852

PennyMillions852 6分前

Cobbed already again this week! .0015...SMFH

TheKid5

TheKid5 6分前

Permit date is July 16th, after 90 day statutory period. We should have spaces calls every couple weeks after that. 🤓
I am not associated with the company, except I am part owner with my equity holdings 😎
BULLISH BULLISH BULLISH!!!!!!!!!

Lakefront Biotherapeutic...

Jpmorgan Chase Financial...

OMX Stockholm Benchmark ...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。